公开(公告)号：KR20070100657A

公开(公告)日：2007-10-11

申请号：KR20070034003

申请日：2007-04-06

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FIBIANO AGNES ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/22

CPC classification number: A61K31/04 ,  A61K31/165

Abstract: A pharmaceutical composition comprising agomelatine is provided to be used for treating generalized anxiety disorder and provide good acceptability profile to patients without side effects such as withdrawal symptoms occurring when being treated by using a conventional psychotropic drug stops. A pharmaceutical composition for treating generalized anxiety disorder comprises agomelatine or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, or a hydrate thereof, or a pharmaceutically acceptable acid or base addition salt thereof, and at least one pharmaceutically acceptable excipient thereof.

Abstract translation: 提供了含有阿莫西拉的药物组合物，用于治疗广泛性焦虑症，并且对于没有副作用的患者提供良好的可接受性，如通过使用常规精神药物停止治疗时出现的戒断症状。 一种用于治疗广泛性焦虑症的药物组合物包括阿米苏定或N- [2-（7-甲氧基-1-萘基）乙基]乙酰胺或其水合物或其药学上可接受的酸或碱加成盐，以及至少一种药学上可接受的盐 其可接受的赋形剂。

公开(公告)号：WO2008071869A2

公开(公告)日：2008-06-19

申请号：PCT/FR2007001925

申请日：2007-11-23

Applicant: SERVIER LAB ,  SPEDDING MICHAEL ,  MOCAER ELISABETH

Inventor： SPEDDING MICHAEL ,  MOCAER ELISABETH

CPC classification number: A61K31/165

Abstract: The invention relates to the use of agomelatine or N-[2-(7-methoxy-1-naphtyl)ethyl]acetamide in order to obtain drugs intended for the treatment of periventricular leukomalacia.

Abstract translation: 本发明涉及阿戈美拉汀或N- [2-（7-甲氧基-1-萘基）乙基]乙酰胺以获得用于治疗脑室周围白质软化症的药物的用途。

公开(公告)号：WO2008071870A3

公开(公告)日：2008-08-14

申请号：PCT/FR2007001926

申请日：2007-11-23

Applicant: SERVIER LAB ,  MOCAER ELISABETH ,  FABIANO AGNES

Inventor： MOCAER ELISABETH ,  FABIANO AGNES

IPC: A61K31/165 ,  A61P25/00

CPC classification number: A61K31/165

Abstract: The invention relates to the use of agomelatine or N-[2-(7-methoxy-1-naphtyl)ethyl]acetamide in order to obtain drugs intended for the treatment of Smith-Magenis syndrome.

Abstract translation: 本发明涉及到用于治疗Smith-Magenis综合征的药物的用途，所述agomelatine或N- [2-（7-甲氧基-1-萘基）乙基]乙酰胺用于获得药物。

公开(公告)号：HRP20180537T1

公开(公告)日：2018-05-04

申请号：HRP20180537

申请日：2018-04-03

Applicant: SERVIER LAB

Inventor： LAIGLE LAURENCE ,  MOCAER ELISABETH ,  MILLAN MARK J

IPC: A61K31/165 ,  A61P25/22

公开(公告)号：MY158112A

公开(公告)日：2016-08-30

申请号：MYPI2012700497

申请日：2011-02-10

Applicant: SERVIER LAB

Inventor： LAIGLE LAURENCE ,  MOCAER ELISABETH ,  MILLAN MARK

Abstract: The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Obsessive-Compulsive Disorder (OCD).

公开(公告)号：EA023473B1

公开(公告)日：2016-06-30

申请号：EA201201123

申请日：2011-02-10

Applicant: SERVIER LAB

Inventor： LAIGLE LAURENCE ,  MOCAER ELISABETH ,  MILLAN MARK J

IPC: A61K31/165 ,  A61P25/22

Abstract: Изобретениекасаетсяпримененияагомелатинаили N-[2-(7-метокси-1-нафтил)этил]ацетамидадляполучениялекарственныхсредств, предназначенныхдлялеченияобсессивно-компульсивногорасстройства (ОКР).

公开(公告)号：CY1111430T1

公开(公告)日：2015-08-05

申请号：CY111100416

申请日：2011-04-27

Applicant: SERVIER LAB

Inventor： MOCAER ELISABETH ,  FABIANO AGNÈS

IPC: A61K31/165 ,  A61P25/00

Abstract: Ηπαρούσαεφεύρεσηαναφέρεταιστηχρήσητηςαγομελατίνηςή Ν-[2-(7-μεθοξυ-1-ναφθυλ)αιθυλ]ακεταμιδίουγιατηλήψηφαρμάκωνπουπροορίζονταιγιατηθεραπείατουσυνδρόμου Smith Magenis.

公开(公告)号：HK1177897A1

公开(公告)日：2013-08-30

申请号：HK13105666

申请日：2013-05-13

Applicant: SERVIER LAB

Inventor： LAIGLE LAURENCE ,  MOCAER ELISABETH ,  MILLAN MARK J

IPC: A61K20060101 ,  A61P20060101

Abstract: The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Obsessive-Compulsive Disorder (OCD).

公开(公告)号：AU2007201527B2

公开(公告)日：2012-08-09

申请号：AU2007201527

申请日：2007-04-05

Applicant: SERVIER LAB

Inventor： DELALLEAU BRUNO ,  FABIANO AGNES ,  MILLAN MARK ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P25/22

Abstract: USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER 5 The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1 naphthyl)ethylacetamide, in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder.

公开(公告)号：AU2007234614B2

公开(公告)日：2012-06-14

申请号：AU2007234614

申请日：2007-11-22

Applicant: SERVIER LAB

Inventor： FABIANO AGNES ,  MOCAER ELISABETH

IPC: A61K31/165 ,  A61P5/00 ,  A61P25/00 ,  A61P25/20

Abstract: The present invention relates to the use of agomelatine, N-[2-(7-methoxy-1 naphthyl)ethyl]acetamide, for the treatment of Smith-Magenis syndrome.